Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may effectively treat alopecia areata without harming hair follicles.

AMP-303 safely increases hair growth in men with hair loss.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Composite biomaterials can precisely control immune responses for better disease treatment.

Imiquimod cream can rarely cause temporary hair loss.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Two new compounds were found to effectively reduce hair growth in mice.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

More research is needed to understand and treat morphea effectively.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

Topical 1% pimecrolimus effectively treated alopecia areata.

A woman's hair loss was likely caused by a cream used for skin treatment and improved after she stopped using it.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.